Entrectinib, sold under the brand name Rozlytrek, is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. It is a selective tyrosine kinase inhibitor (TKI), of the tropomyosin receptor kinases (TRK) A, B and C, C-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK).

From Wikipedia (CC BY-SA 4.0).

Also known as NMS-E628, RXDX-101

On IJR

No public IJR answers mention entrectinib yet. As people ask about it and share their answers, they'll appear here.

Facts from Wikidata (CC0).

Overview

From Wikipedia (CC BY-SA 4.0).